Streamex Corp.

STEX Nasdaq CIK: 0001530766

Company Information

Industry Electromedical & Electrotherapeutic Apparatus
SIC Code 3845
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation DE
Business Address 2431 ALOMA AVENUE, WINTER PARK, FL, 32792
Mailing Address 2431 ALOMA AVENUE, WINTER PARK, FL, 32792
Phone (203) 409-5444
Fiscal Year End 1231
EIN 264333375

Financial Overview

FY2025

-$10.33M
Net Income
$54.22M
Total Liabilities
$-0.75
EPS

Recent SEC Filings

Form Type Date Filed Document
10-K Annual financial report March 31, 2026 View on SEC
8-K Current report of material events March 27, 2026 View on SEC
4 Insider stock transaction report March 26, 2026 View on SEC
3 Initial insider ownership report March 26, 2026 View on SEC
8-K Current report of material events March 20, 2026 View on SEC
3 Initial insider ownership report March 9, 2026 View on SEC
8-K Current report of material events March 6, 2026 View on SEC
4 Insider stock transaction report February 24, 2026 View on SEC
4 Insider stock transaction report February 18, 2026 View on SEC
424B5 Prospectus supplement February 13, 2026 View on SEC

Annual Reports

10-K March 31, 2026
  • Strategic pivot to Real-World Asset (RWA) tokenization, specifically gold (GLDY).
  • Infrastructure-focused business model generating revenue through transaction fees.
View Analysis

Material Events

8-K Acquisition December 16, 2025
High Impact
  • Streamex Corp. acquired a 9.9% ownership stake in Empress Royalty Corp., a gold and silver royalties company.
  • The acquisition was valued at approximately US$12.2 million and was paid for by issuing 2,443,750 Streamex shares.
View Analysis

Insider Trading

STRONG BUY 3 insiders 10 recent transactions
View Full Insider Trading Profile

Related Companies

Companies in the same industry (SIC: 3845)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.